Last $1.00 USD
Change Today +0.007 / 0.71%
Volume 77.8K
ENZN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew Rackear J.D.

Former Chief Compliance Officer, Head of Human Resources, Vice President, General Counsel and Secretary, Enzon Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

59$1,161,029
As of Fiscal Year 2013

Background*

Mr. Andrew Rackear, JD, served as the General Counsel and Secretary of Enzon Pharmaceuticals Inc. since April 2010 until November 30, 2013 and also served as its Vice President and Head of Human Resources. Mr. Rackear served as the Chief Compliance Officer of Enzon Pharmaceuticals since September 2010. Mr. Rackear served as Secretary and General Counsel of APBiotech Inc. Mr. Rackear served as Senior Vice President of Legal Affairs, General Counsel of NPS Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

20 Kingsbridge Road
Piscataway, New Jersey 08854

United States

Phone: 732-980-4500
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

JD 1980
New York University School Of Law
BA
University of Rochester

Other Affiliations*

Annual Compensation*

Salary$357,979
Total Annual Compensation$357,979

Stock Options*

All Other Compensation$803,050
Exercisable Options6,250
Unexercisable Options18,750
Total Number of Options43,750

Total Compensation*

Total Annual Cash Compensation$1,161,029
Total Short Term Compensation$357,979
Other Long Term Compensation$803,050
Total Calculated Compensation$1,161,029
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZN:US $1.00 USD +0.007

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
Onxeo SA
€276.9K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
William John Edward Burt DPhilChief Executive Officer and Executive Director
Abzena plc
--
Kleanthis G. Xanthopoulos Ph.D.Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Regulus Therapeutics Inc.
$600.0K
Compensation as of Fiscal Year 2012.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.